— Know what they know.
Not Investment Advice

BST.MC BME

Biotechnologies Assets S.A.
1W: -6.0% 1M: -11.7% 3M: -12.2% YTD: -6.0% 1Y: -59.0% 3Y: -56.9% 5Y: -57.8%
€0.19 ($0.21)
-0.00 (-1.83%)
 
Weekly Expected Move ±5.8%
€0 €0 €0 €0 €0
BME · Healthcare · Biotechnology · Tech Score Sell · Power 37 · €14.1M mcap · 35M float · 0.355% daily turnover
Smart Money Score
No convergence signal
Key Statistics
Market Cap€14.1M ($15.8M)
52W Range0.176-0.431
Volume195,346
Avg Volume125,279
Beta1.82
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOManuel Lopez Nieto
Employees26
SectorHealthcare
IndustryBiotechnology
IPO Date2012-01-26
Av. del Desarrollo Tecnológico, 11
Cádiz, AN 11591
ES
34 85 681 84 24
About Biotechnologies Assets S.A.

Biotechnologies Assets S.A. is dedicated to conceiving, producing, and commercializing sophisticated biotechnological assets. These innovative materials are utilized across a diverse array of sectors, including biopharmaceuticals, agriculture, cosmetics, animal health, and the broader chemical industry. The company operates globally, with its headquarters located in Cádiz, Spain, where it was established in 1954.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms